Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.
about
Antibiotics for secondary prevention of coronary heart diseaseGut flora metabolism of phosphatidylcholine promotes cardiovascular diseasePeptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugsHelicobacter pyloriNon-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibodyRole of Helicobacter pylori infection in pathogenesis of atherosclerosisEffect of Helicobacter pylori infection on blood pressure: a community based cross sectional studyHelicobacter pylori infection and fasting plasma glucose concentrationLong-term trends in cardiovascular disease mortality and association with respiratory disease.[Epidemiological aspects of Helicobacter pylori infection in childhood and adolescence].C-reactive protein as a marker for active coronary artery disease in patients with chest pain in the emergency room.Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review.Dental plaque, platelets, and cardiovascular diseases.Chlamydia pneumoniae and atherosclerosis.Chlamydia pneumoniae and coronary heart disease.Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce.Helicobacter pylori and extra-digestive diseases.Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies.Occupational exposure to dust: inflammation and ischaemic heart diseaseSystemic inflammation in cardiovascular and periodontal disease: comparative studyDetection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCRChlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individualsWeighing the evidence for infection as a risk factor for coronary heart disease.Should antibiotics now be part of routine treatment of coronary heart disease?Helicobacter pylori-related diseases.The gut microbiota, environment and diseases of modern society.The role of risk factors in the development of atherosclerosis.The relationship between infection, inflammation, and cardiovascular disease: an overview.The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease.Helicobacter pylori eradication lowers serum homocysteine level in patients without gastric atrophy.Constipation and risk of cardiovascular disease among postmenopausal women.Is periodontitis associated with an increased risk of coronary heart disease and preterm and/or low birth weight births?Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.Inflammatory and thrombotic mechanisms in coronary atherosclerosisA high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis.Helicobacter pylori gastritis, a presequeale to coronary plaque.Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profileChronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease.Seasonal variations in out of hospital cardiopulmonary arrest.Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status
P2860
Q24201388-447D5A23-CDA7-401B-9D99-A2BB1D2D06BDQ24601951-5FF6FF6F-71BB-4BF5-999F-AEBDB1BA266AQ24673221-7B7F2220-32FF-4683-934D-4A38DD83B5FFQ24683623-C935F7EF-0A8F-45AE-AAFA-37CE5511D21FQ24804167-24CC3FB0-E44E-477A-8505-F436181B30C3Q27002402-B3ADF49B-4087-4FDD-8990-E61E2516B310Q28345336-C8E30B9E-7E36-4A79-82D9-3318E8F64698Q28365939-DDF392A8-C37B-42A9-B47A-7D7F6D3FA14FQ30377539-F7AC5E56-7498-4AEF-BA84-202AD800EC61Q30838023-BA7DDA97-6D14-4B0E-93EB-3172C8D9F90DQ31113902-D7412E9B-24BB-43EE-BCA8-0C3A1B47B470Q33401864-E0691975-35F5-43D2-9555-D17F5BF79485Q33503491-014528D5-928F-434C-84A0-4ABCFB368E78Q33534714-6B03CA0D-FE50-4107-AE69-12E4C7064F2BQ33659387-2B51C242-6A89-4697-B676-A6D5BC10CD2BQ33703897-38683BBC-651C-4903-90A4-E0DDA515C676Q33760044-5471AAC1-58FA-49AF-B29B-A0FDA319B4DCQ33776566-E8AC60A3-AA74-4A8C-A1F5-37C9A328332FQ33820733-2B773584-BCA7-4379-844B-CE5482A3B5FCQ33941972-546DFE24-7136-4C3D-8483-529A8A56135DQ33970537-9EF7D543-F18A-4AA6-B8BA-B6816F283C30Q33972282-207E5307-D5AB-4B9D-A6F0-4D12D42904FBQ34011168-83E8C8D9-45D9-4426-95C4-D1C3F8AAAB4DQ34160606-93FE7776-4356-464E-B5FE-F52018713F88Q34266402-12DEE00B-5323-41D5-A3F9-DB6933264BE8Q34348985-44E2B0A9-7F44-4A7A-907D-139E1AB37D73Q34447107-BFA33F63-075B-40EA-8174-149138679AC1Q34557639-1B7439E8-F660-4385-8B7E-303DA568FEF0Q34557697-2D7E6DFA-5DD8-4E56-BB1F-187546C13104Q35011253-B04F099A-E749-40F5-A82D-04643B856DDAQ35129733-A406CF1B-D4FD-4339-A197-F503447560D4Q35145332-64E9FDF3-8568-4A75-864E-3C25991336B9Q35147488-E08825D6-853C-471F-B9D9-8DA291F964E2Q35201247-CAAE3270-68C5-4B9E-8495-97ADE72750D0Q35203718-7D5D7A4F-C960-4B24-9B21-E303316A39CFQ35289835-5650AC2C-51A0-4823-A685-DBD3ABF55CF6Q35370873-48F02901-E394-4D1F-8516-9FD89C14FF9FQ35371043-928455D0-1AE0-4137-8D2C-8B5CA71098B9Q35374019-09011DE0-7708-4130-94F0-46CE7F17E5F6Q35413402-52FB3B65-075E-41AA-A040-C12AEDD193C2
P2860
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1995
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of Helicobacter py ...... d cardiovascular risk factors.
@en
Association of Helicobacter py ...... d cardiovascular risk factors.
@nl
type
label
Association of Helicobacter py ...... d cardiovascular risk factors.
@en
Association of Helicobacter py ...... d cardiovascular risk factors.
@nl
prefLabel
Association of Helicobacter py ...... d cardiovascular risk factors.
@en
Association of Helicobacter py ...... d cardiovascular risk factors.
@nl
P2093
P2860
P356
P1433
P1476
Association of Helicobacter py ...... d cardiovascular risk factors.
@en
P2093
Blakeston C
Carrington D
Mendall MA
Molineaux N
Seymour CA
Strachan DP
P2860
P304
P356
10.1136/BMJ.311.7007.711
P407
P577
1995-09-01T00:00:00Z